DDIT3 and diffuse large B-cell lymphoma: R‐IPI was originally proposed as a better predictor of survival for patients with DLBCL in the era of R‐CHOP.16 In accordance with the results in DLBCL, our results also showed the superiority of R‐IPI to IPI in patients with DLBCL‐GL, which might be related to that of our cohort included a large proportion of advanced stage.